Gaijin Panty

It’s important to cover the ends of extension ladder rails with protective covers to keep from damaging your house. Watch this video to find out how to make ladder covers the easy way using a foam pool noodle.

7, 2018 /PRNewswire/ — PolarityTE, Inc. (Nasdaq: COOL), a commercial-stage biotechnology and regenerative biomaterials company, today issued …

BIO is pleased to announce the winners of the 2018 BIO Investor Forum Buzz of BIO contest, which recognizes highly innovative companies in the biotech sector. Ten pioneering biotech companies were nominated in each of three categories-Early Stage Entrepreneurs, Late Stage Leaders, and Diagnostics and Beyond. Voting closed August 30.

Locus Biosciences, a private, emerging biotechnology company, won in the Early Stage Entrepreneurs category. Locus Biosciences is developing CRISPR-engineered precision antibacterial products to address critical unmet medical needs in antibiotic-resistant bacterial infections and microbiome-related disease. Learn more about Locus Biosciences.

Garnering the most votes in the Late Stage Leaders category was Caladrius Biosciences (NASDAQ: CLBS), a clinical stage development company with cell therapy products in development based on multiple technology platforms and targeting autoimmune and select cardiology indications. The Company is investigating its lead product candidate, CLBS03, an ex vivo expanded polyclonal T regulatory cell therapy for the treatment of recent-onset type 1 diabetes in a currently enrolling Phase 2 trial. Learn more about Caladrius Biosciences.

In the category of Diagnostics and Beyond, QT Medical, a medical device startup, took home the grand prize. QT Medical aims to make high quality 12-lead electrocardiogram (ECG) available to everyone. QT ECG™, the first product of QT Medical, is the world’s most compact 12-lead ECG system. Focusing on innovations in the field of telemedicine and home care, QT Medical invests in research and development of products that will bring better cardiac care to patients. Learn more about QT Medical.

Congratulations to the three companies! Each will receive complimentary conference registration and a company presentation.

The BIO Investor Forum will take place October 17-18 at the Westin St. Francis Hotel in San Francisco and will focus on investment opportunities for early stage and established private companies as well as emerging public companies.

Advance media registration is now available for qualified reporters working full time for print, broadcast and web publications with valid press credentials.

Visit us to learn more about the BIO Investor Forum, including registration, programming, company presentations and partnering information.

Another major issue, especially for Senators Marco Rubio and Tom Cotton, was the degree to which Facebook, Twitter and Google should be aligned …

Brazil’s vast, fertile landscape – covering 47 percent of the South American continent – is known for its biodiversity. And thanks to a favorable regulatory landscape and abundant scientific ingenuity, the country is also quickly earning a reputation as an incubator for agricultural innovation.

In fact, of the more than 300 biotechnology startups in Brazil, nearly half are working on breakthroughs to help farmers and the consumers who depend on them.

This week, Brazil’s growing biotech footprint in the food and agriculture sector will be front and center at the 2018 BIO Latin America conference in South America’s largest city, São Paulo. The conference will bring together 500 biotech leaders from more than 20 countries to network, learn and partner with one another to promote biotechnology innovation.

Brazil has increased its life science R&D spending over the past decade. This week’s conference seeks to promote additional investment in biotechnology research to support small innovators in the region. Several Brazilian agriculture companies are on course to deliver important new technologies to feed a rapidly growing global population that is expected to reach 9 billion people in 30 years.

However, increased awareness and capital is needed to take their ideas from the lab to the commercial marketplace.

To showcase some of these emerging companies, BIO is bringing its Start-up Stadium program to BIO Latin America for the first time this year. Start-Up Stadium allows emerging companies, entrepreneurs and innovators to pitch their technology to potential investors, so they can secure feedback and funding to grow their businesses.

Also, for the first time, BIO Latin America will include ag programming to accompany panels on biopharmaceuticals and industrial biotech – with a special focus on the “Promise of Agricultural Biotechnology for a Sustainable World.”

One of the innovative companies presenting at Start-Up Stadium is LOTAN Agrosciences, which was founded in 2016 by two young Brazilian researchers from the University of São Paulo. LOTAN develops topical pesticides based on RNA interference (RNAi) – a technique used by scientists to suppress the activity of specific genes. LOTAN’s pesticide technology silences a plant’s genes without any heritable effects on the plant’s DNA. Through this technology, Brazilian farmers won’t have to worry that a plant will develop pesticide tolerance from repeated sprayings over generations.

RNAi will become increasingly critical as Brazil continues to increase cultivation and export of genetically modified crops. Currently, Brazil is second only to the United States in the production of GM crops.

YLive, another Brazilian biotech presenting at Start-Up Stadium, focuses on developing natural probiotics to increase animal productivity and improve immune health. This is crucial for an economy that ranks among the world’s largest for beef exports. Through advances in animal productivity, YLive can reduce its environmental impact by producing animal protein more sustainably.

In addition to Start-Up Stadium, BIO Latin America will host more than 2,500 business meetings through BIO’s One-on-One Partnering system. In those meetings, emerging companies in health, agriculture and industrial biotechnology will have the opportunity to seek partnerships and capital by sitting down with other innovators and investors from across Latin America.

Enterprising startups like YLive and LOTAN Agrosciences demonstrate the tremendous potential of Brazil’s burgeoning agricultural biotechnology sector. BIO Latin America provides the platform for these companies to share their products, grow their bottom lines and scale up cutting-edge technologies on a global scale to help feed a growing world.

For more information about 2018 BIO Latin America, click here.

Insulation is important to the energy efficiency of your home. But have you ever thought that insulation can also protect your home in the event of a fire? Check out this insulation we love to use!

The story could start with a farmer and a food scientist walk into a bar…or a restaurant…or a grocery store…or the Food Expo at IFT18: A Matter of Science and Food. Although they stand at opposite ends of the food chain, their topic of conversation is food - sustainability, security, waste and innovation.

GMO Answers volunteer expert and farmer Katie Pratt joined GMO Answers at their booth during the Institute of Food Technologists (IFT) Convention in Chicago in July. Katie and her husband, Andy, are seventh generation farmers raising farm kids, corn, soybeans, and seed corn with Andy’s family in north central Illinois.

She talked to many food scientists, nutritionists, technologists, and marketing professionals. During the show, Katie did a Facebook Live video for GMO Answers, with some initial thoughts about her conversations and engagements.

After the show, and with some time to look back and reflect on her experience, she wrote a blog post for the GMO Answers Medium page. Her main theme: Farmers, scientists and researchers have a message for you: GMOs are safe! But this message is getting muddled due to a lack in science literacy.

Her three main takeaways:

• Food scientists support science. The majority of the people who stopped at the GMO Answers booth did so to say, “Thanks for being here. We need people talking about GMOs, about science.”
• Crafting a scientific message that can be - should be - heard by their marketing counterparts is a great source of frustration for food scientists.
• The discussion of sustainability, food insecurity and food waste are everywhere! From small-town USA to the developing world, our planet is hungry and our ability to understand science affects our ability to innovate, to discover solutions to very timely problems.

Ultimately, science literacy must make a comeback in our schools, in our universities, in our daily conversations. Because when we understand the world around us, be it a field, a pasture, a laboratory or a bar, our ability to do better grows.

For more about GMOs, please visit the GMO Answers website.

Growing allegations that Facebook, Google and Twitter limit the reach of conservative voices and viewpoints on their platforms is the latest political …

August marks National Immunization Awareness Month – a time to take inventory on where we stand, and recognize how far we’ve come, in advancing breakthrough vaccines designed to protect the world’s population. However, despite the clear societal and economic benefits that come with common vaccinations like a flu shot, distorted facts and misinformation about immunization often stand between these extraordinary products and the populations that urgently need them. Regardless of a greater portion of society agreeing that the benefits outweigh the risks, year-round efforts to ensure individuals across the globe are educated with the facts on vaccine safety and effectiveness are more important than ever.

And the facts are now beyond doubt. One estimate found that between 2011 and 2020, vaccines will have averted over 23 million deaths in low-income countries. What’s more, according to the CDC, vaccines are responsible for saving the lives of more than 730,000 American children between 1994-2013. During this same period, more than 320 million childhood illnesses were prevented in the U.S. alone.

But it’s not just children who benefit from vaccines. Men and women of all ages should make sure they are up to date – especially as individuals age and their immune systems weaken. In the U.S., the Alliance for Aging Research found that between 50,000 and 90,000 adults die annually from vaccine-preventable diseases or their complications. Each one of those deaths is a terrible tragedy that could easily be avoided with more widespread vaccination.

Beyond the impact on our lives and health, vaccines also have a tremendous positive economic impact. American businesses lose billions of dollars in lost productivity each year because of employees falling ill from sicknesses that vaccines could have helped prevent. In fact, one estimate predicted that 11 million workers would become sick with the flu during the 2018 winter season, costing their employers over $9 billion in sick leave. Another study found that the vaccination of children born in the United States in 2009 is projected to generate $184 billion in lifetime social value – that’s about $45,000 per child.

The data speaks for itself: from both an economic and public health standpoint, vaccines have the ability to shape and change the world. Take polio for example. An outbreak in 1952 took the lives of 3,000 Americans, paralyzing another 21,000 in that same year. Families were broken, communities were devastated, and our country lived in fear. What seemed like an unbeatable challenge, however, was no match for science. Years of R&D and sleepless nights led many brilliant scientists to a vaccine for the virus by 1955. In 1979, polio, once our nation’s most feared disease, was officially eliminated in the United States.

Shingles is another condition that we now have the tools to conquer. This painful rash, often described as debilitating and intense, can last for weeks, and feel like an eternity for many patients. But the past few years have brought welcome news. The CDC now recommends two vaccines for adults age 50 years or older, and these modern marvels are highly effective at reducing the severity of shingles pain which is an incredible step forward in the fight against this debilitating illness.

It’s also encouraging to see researchers and scientists’ race against time to prevent emerging viral diseases like Zika, Ebola, or Middle East Respiratory Syndrome (MERS) from spreading and thus causing an unpredictable outbreak. As Dr. Michael Ryan of the World Health Organization recently explained, new tools and resources are being used to control Ebola as we speak. After spending time on the ground with vaccination teams and families in the Democratic Republic of Congo, Dr. Ryan added, “for the first time in my experience, I saw hope in the face of Ebola and not terror.”

Today, more than 260 vaccines are in development to both prevent and treat diseases. The pipeline includes a vaccine to prevent HIV and a therapy focused on combating Alzheimer’s, among others. The science is incredible, but as a society we must do our part. Talk to your loved ones – family, friends, colleagues, or peers – and spread the word about the benefits of getting vaccinated. For ourselves and for our children and grandchildren, we can’t afford to do otherwise.

Phyllis Arthur is the Vice President for Infectious Diseases and Diagnostics Policy at BIO, responsible for working with member companies in vaccines, molecular diagnostics and bio-defense on policy, legislative and regulatory issues.

Foreign Affairs Minister Chrystia Freeland meets with reporters following a day filled with NAFTA negotiations, as a Friday deadline looms.

For more info, please go to https://globalnews.ca/news/4416396/chrystia-freeland-intense-nafta-talks/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
[Read More …]